Diagnosis and Management of Hyponatremia with Elevated Urinary Sodium

Diagnostic Characteristics of SIADH

• The American Thoracic Society recommends that SIADH be characterized by hyponatremia (serum sodium <134 mEq/L), hypoosmolality (plasma osmolality <275 mosm/kg), inappropriately elevated urinary osmolality (>500 mosm/kg), elevated urinary sodium (>20-40 mEq/L), absence of hypothyroidism, adrenal insufficiency, or volume depletion, and euvolemia 1
• The presence of low serum uric acid (<4 mg/dL) has a positive predictive value of 73-100% for SIADH 2, 3

Differential Diagnosis

• Euvolemic hyponatremia (SIADH) is characterized by elevated urinary sodium (>20-40 mEq/L), elevated urinary osmolality (>300 mosm/kg), and euvolemia, with common causes including neoplasms, CNS disorders, and medications 1
• Hypovolemic hyponatremia with elevated urinary sodium is characterized by signs of volume depletion, elevated urinary sodium (>20 mEq/L), and common causes including cerebral salt wasting (CSW), diuretic use, adrenal insufficiency, and salt-losing nephropathy 2, 4
• Hypervolemic hyponatremia with elevated urinary sodium is characterized by signs of volume overload, elevated urinary sodium (>20 mEq/L), and common causes including advanced renal failure 5, 4

Diagnostic Evaluation

• Determining the volume status (hypovolemic, euvolemic, or hypervolemic) is crucial in distinguishing between different causes of hyponatremia 4
• Measuring serum and urinary osmolality, urinary sodium, and evaluating renal, thyroid, and adrenal function are essential in the diagnostic workup 1, 4

Treatment

• The American Thoracic Society recommends fluid restriction (<1 L/day) as the first-line treatment for SIADH, with hypertonic saline (3% solution) reserved for severe or symptomatic cases (serum sodium <120 mEq/L) 1, 4
• For CSW, volume replacement with isotonic saline and consideration of fludrocortisone are recommended, while avoiding fluid restriction 2, 3, 4

Correction Rate

• The correction rate of hyponatremia should not exceed 8 mmol/L in 24 hours to prevent osmotic demyelination syndrome, with more cautious correction (4-6 mmol/L per day) recommended for high-risk patients (advanced liver disease, alcoholism, malnutrition) 2, 4

Monitoring

• Frequent monitoring of serum sodium levels is essential during the correction phase, especially in patients with severe symptoms or high-risk conditions 4
• Signs of osmotic demyelination syndrome (dysarthria, dysphagia, oculomotor dysfunction, quadriparesis) should be vigilantly monitored, typically appearing 2-7 days after rapid correction 4

Workup of Hyponatremia

Initial Assessment

• The initial workup of hyponatremia should include measuring serum and urine osmolality, urine electrolytes, uric acid, and assessment of extracellular fluid volume status to determine the underlying cause 6
• A serum Na value <131 mmol/L should prompt a comprehensive workup 6, 7
• Normal or high serum osmolality may indicate pseudohyponatremia from laboratory error, hyperglycemia, or hypertriglyceridemia 6

Volume Status Assessment

• Physical examination alone has been shown to be inaccurate for determining ECF status (sensitivity 41.1%, specificity 80%) 8
• Hypovolemic signs include orthostatic hypotension, dry mucous membranes, decreased skin turgor 8
• A urinary sodium level <30 mmol/L has a positive predictive value of 71-100% for an infusion of 0.9% saline to increase the serum sodium level 8

Diagnostic Algorithm

• Rule out pseudohyponatremia by checking serum osmolality (normal: 275-290 mOsm/kg) 6
• For euvolemic hyponatremia, rule out hypothyroidism, hypocortisolism, and polydipsia, and check urine osmolality: >100 mOsm/kg with urine sodium >40 mEq/L suggests SIADH 6
• Obtaining levels of hormones such as ADH and natriuretic peptides is not supported by the literature (class III evidence) 6, 7

Special Considerations

• In neurosurgical patients, distinguish between SIADH and cerebral salt wasting (CSW), as treatment approaches differ significantly 8
• Misdiagnosis of volume status can lead to inappropriate therapy and worsened outcomes, and relying solely on physical examination to determine volume status is not recommended 8

Hyponatremia Diagnosis and Management

Classification and Diagnostic Approach

• Hypovolemic hyponatremia is characterized by decreased extracellular fluid volume and signs of dehydration, with urinary sodium <30 mmol/L suggesting extrarenal losses, and urinary sodium >20 mmol/L suggesting renal losses, according to Neurosurgery guidelines 9
• Urinary sodium concentration helps differentiate between renal and extrarenal causes of hyponatremia, with a study published in Neurosurgery in 2009 supporting this approach 9
• Serum uric acid <4 mg/dL has a positive predictive value of 73-100% for SIADH, although it may also be seen in cerebral salt wasting, as noted in Neurosurgery 9
• Physical examination alone has limited accuracy for determining volume status, with sensitivity 41.1% and specificity 80%, as reported in Neurosurgery 9

Special Considerations in Neurological Patients

• In neurosurgical patients, distinguishing between SIADH and cerebral salt wasting (CSW) is critical, as treatment approaches differ significantly, and central venous pressure (CVP) can help determine intravascular volume status, according to Neurosurgery guidelines 9
• CSW is characterized by hypovolemia with CVP <6 cm H₂O, while SIADH typically has normal volume with CVP 6-10 cm H₂O, as described in Neurosurgery 9

Diagnostic Approach to SIADH

Essential Laboratory Tests and Diagnostic Criteria

• In elderly patients with impaired renal function, serum osmolality >300 mOsm/kg indicates dehydration, not SIADH, according to Clinical Nutrition guidelines 10, 11
• The European Society of Clinical Nutrition and Metabolism recommends assessing volume status clinically and correlating with laboratory data, as physical examination alone has poor accuracy (sensitivity 41.1%, specificity 80%) in patients with impaired renal function 10, 11

Tests NOT Recommended

• The American Society for Nutrition does not support routine ordering of plasma ADH levels, as it is not supported by evidence and delays diagnosis, and also does not recommend natriuretic peptide levels or bioelectrical impedance for hydration assessment in elderly patients with impaired renal function 10, 11